Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=78 Randomized Single-blind Supportive Care

In-Home Technology for Dementia Caregivers

Dementia · Alzheimer's Disease · Frontotemporal Dementia

Bottom Line

View on ClinicalTrials.gov: NCT03828383 ↗
Enrolled (actual)
78
Serious AEs
0.0%
Results posted
May 2022
Primary outcome: Primary: Zarit Burden Interview-Short Form — 24.58; 25.59 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
In-home technology (Device); Limited in-home technology (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, Berkeley
Primary completion
Nov 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Zarit Burden Interview-Short Form		 24.58; 25.59 —
PRIMARY
Center for Epidemiological Studies Depression Scale (CES-D)		 19.21; 19.30 —
PRIMARY
Beck Anxiety Inventory (BAI)		 7.74; 11.20 —
PRIMARY
Satisfaction With Life Scale		 17.35; 19.00 —

Summary

This study aims to develop and evaluate in-home assistive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease and frontotemporal dementia.

Eligibility Criteria

Inclusion Criteria

  • Caregivers are fluent/literate in English
  • Caregivers currently reside with spouse/family member with dementia
  • Caregivers primarily use an iPhone
  • Caregiver has wireless internet in home

Exclusion Criteria

  • Caregivers providing care for individuals with known non-neurodegenerative conditions affecting behavior and cognition
  • Caregivers providing care for individuals with longstanding Axis I psychiatric disorder
  • Caregivers providing care for individuals with metabolic disorder or major organ dysfunction
  • Caregivers providing care for individuals with alcohol abuse or dependence (within 5 years of dementia onset)
  • Caregivers providing care for individuals with head trauma with loss of consciousness greater than 30 minutes
  • Caregivers providing care for individuals with contraindications to MRI imaging
  • Caregivers providing care for individuals with large confluent white matter lesions
  • Caregivers providing care for individuals with significant systemic medical illness
  • Caregivers providing care for individuals who use a medication likely to affect central nervous system functions adversely

If you live in the San Francisco Bay Area, Las Vegas (Clark County), Orange County, Los Angeles County, or Oregon, you may complete the following screening questionnaire to determine your eligibility for participation: https://bit.ly/UCBDC Upon completion of the screening questionnaire, the UC Berkeley research team will follow up soon after by email or phone to confirm your eligibility status.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03828383). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search